Maternal Diabetes and Neurodevelopmental Outcomes of Infants Born Before 29 Weeks' Gestation
Adetokunbo Akinseye,Christy Pylypjuk,Diane Moddemann,Jehier Afifi,Rudaina Banihani,Khalid Aziz,Dianna Wang,Mary Seshia,Canadian Neonatal Network, Canadian Neonatal Follow-Up Network under the Umbrella of Canadian Preterm Birth Network,Prakesh S Shah,Marc Beltempo,Jaideep Kanungo,Joseph Ting,Zenon Cieslak,Rebecca Sherlock,Ayman Abou Mehrem,Jennifer Toye,Carlos Fajardo,Jaya Bodani,Lannae Strueby,Deepak Louis,Ruben Alvaro,Amit Mukerji,Orlando Da Silva,Sajit Augustine,Kyong-Soon Lee,Eugene Ng,Brigitte Lemyre,Thierry Daboval,Faiza Khurshid,Victoria Bizgu,Keith Barrington,Anie Lapoint,Christine Drolet,Bruno Piedboeuf,Martine Claveau,Marie St-Hilaire,Roderick Canning,Hala Makary,Cecil Ojah,Luis Monterrosa,Julie Emberley,Andrzej Kajetanowicz,Shoo K Lee,Thevanisha Pillay,Anne Synnes,Jill Zwicker,Miroslav Stavel,Anitha Moodley,Leonora Hendson,Amber Reichert,Matthew Hicks,Cecilia de Cabo,M Florencia Ricci,Sarah McKnight,Kevin Coughlin,Linh Ly,Edmond Kelly,Paige Church,Kim-Anh Nguyen,Ruth Mandel,Alyssa Morin,Sylvie Belanger
DOI: https://doi.org/10.1016/j.jpeds.2024.114319
2024-09-19
Abstract:Objective: To compare the neurodevelopmental outcomes of infants born at <29 weeks' gestation and exposed to diabetes in pregnancy with those unexposed. Study design: This was a retrospective cohort study using the Canadian Neonatal Network and Canadian Neonatal Follow-Up Network databases. Infants born <29 weeks' gestation and admitted to a level 3 neonatal intensive care unit from 2009 through 2018 who had neurodevelopmental assessments at 18-24 months corrected age were eligible. The 2 primary outcomes were as follows: (1) Neurodevelopmental impairment (NDI) (≥1 of Bayley-III scores < 85 in any domain, cerebral palsy, or vision or hearing impairment); and (2) significant NDI (sNDI) (≥1 of Bayley-III scores < 70 in any domain, cerebral palsy Gross Motor Function Classification System ≥ 3, bilateral blindness, or need for hearing aids or cochlear implants). Secondary outcomes were the individual components of NDI and sNDI. Adjusted odds ratios with 95% CIs were calculated to determine outcomes between groups. Results: Of 13 988 eligible infants, 55% attended neurodevelopmental follow-up assessments. Infants exposed to diabetes had increased odds of NDI compared with those unexposed (aOR 1.09 (95% CI 1.08-1.54); there was no difference in sNDI (aOR 1.07 (95% CI 0.84-1.36). Language and motor delays were more common in those exposed to maternal diabetes. Conclusions: Higher rates of NDI, language, or motor delays were present in infants born at <29 weeks' gestation exposed to diabetes in utero. Future research is needed to determine the etiology and clinical significance of these findings.